Cargando…
Peptide-based delivery of therapeutics in cancer treatment
Current delivery strategies for cancer therapeutics commonly cause significant systemic side effects due to required high doses of therapeutic, inefficient cellular uptake of drug, and poor cell selectivity. Peptide-based delivery systems have shown the ability to alleviate these issues and can sign...
Autores principales: | Samec, Timothy, Boulos, Jessica, Gilmore, Serena, Hazelton, Anthony, Alexander-Bryant, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010702/ https://www.ncbi.nlm.nih.gov/pubmed/35434595 http://dx.doi.org/10.1016/j.mtbio.2022.100248 |
Ejemplares similares
-
Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
por: Samec, Timothy, et al.
Publicado: (2022) -
Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery
por: Boisguérin, Prisca, et al.
Publicado: (2021) -
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
por: McClorey, Graham, et al.
Publicado: (2018) -
Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides
por: Wickline, Samuel A., et al.
Publicado: (2023) -
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
por: Alabsi, Wafaa, et al.
Publicado: (2022)